IRVINE, Calif., Sept. 05, 2017 -- Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against TransDigm Group Incorporated (“TransDigm” or the “Company”) (NYSE:TDG). Investors who purchased or otherwise acquired TransDigm shares between May 10, 2016 and January 19, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the October 10, 2017 lead plaintiff motion deadline.
If you purchased TransDigm shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.
According to the Complaint, during the Class Period, TransDigm made false and/or misleading statements and/or failed to disclose: that the Company’s growth and profitability were artificially inflated as a result of its illicit business practices; that TransDigm used exclusive distributors to make noncompetitive government bids seems competitive; that the Company’s subsidiaries failed to list TransDigm as a parent entity when submitting government bids; and that as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. Upon this information, shares of TransDigm dropped in value materially, which caused investors harm according to the Complaint.
If you wish to learn more about this lawsuit, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at [email protected].
This press release may constitute Attorney Advertising in some jurisdictions.
Contact Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 [email protected]


Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Apple Turns 50: From Garage Startup to AI Crossroads
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 



